Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion.
D000818:Animals; D003327:Coronary Disease / Q000188:drug therapy*; D003331:Coronary Vessels / Q000601:surgery; D003402:Creatine Kinase / Q000378:metabolism; D004195:Disease Models, Animal; D004285:Dogs; D004338:Drug Combinations; D004562:Electrocardiography; D005947:Glucose / Q000627:therapeutic use*; D006019:Glycolysis; D007263:Infusions, Parenteral; D007328:Insulin / Q000627:therapeutic use*; D008026:Ligation; D008854:Microscopy, Electron; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000473:pathology; D009206:Myocardium / Q000201:enzymology / Q000473:pathology; D009336:Necrosis / Q000473:pathology; D011188:Potassium / Q000627:therapeutic use*; D011433:Propranolol / Q000627:therapeutic use*; D013997:Time Factors
D004338:Drug Combinations; D007328:Insulin; D011433:Propranolol; D003402:Creatine Kinase; D005947:Glucose; D011188:Potassium